Skip to main content
Fig. 6 | BMC Medicine

Fig. 6

From: 5mC regulator-mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer

Fig. 6

The 5mC score predicted the response to immunotherapy in several immunotherapy cohorts. A Non-small-cell lung cancer (GSE135222 cohort): The upper part indicates the proportion of patients who responded to ICB in the low and high 5mC score groups; the lower part shows the survival analysis of the 5mC score groups. B–H Melanoma (Six ICB cohorts: GSE78220, Nathanson2017 pre, Nathanson2017 post, VanAllen2015, Gide2019, and GSE91061 cohorts; One adoptive T cell therapy cohort: Lauss2017 cohort): Upper part indicated the proportion of patients with responses to immunotherapy in low and high 5mC score groups; lower part shows the survival analysis of 5mC score groups

Back to article page